retatrutide trial safety ESC 2024: improves lipid and cardiovascular risk profile in Phase II Retatrutide Severe Obesity Trial Shows

Through differentiated development strategies and novel mechanisms that address unmet needs in obesity treatment, Hanmi is committed to becoming a global leader in obesity innovation

New preclinical study provides novel insights into how GIP and GLP-1 work together in the brain to drive weight loss

The Gallup Poll found that overall, use of semaglutide medicines or liraglutides doubled from nearly 6% in the first quarter of 2024 to over 12% in Q2 + Q3 in 2025

These pockets occur when the inner layer of the digestive tract pushes through weak spots in the outer layer

Impulse buys just

Understanding your biomarker profile and genetic predispositions in peptide pathways may help inform your provider's dosing strategy and expectations for response patterns